AU3580001A - Modulators of the endocannabinoid uptake and of the vallinoid receptors - Google Patents

Modulators of the endocannabinoid uptake and of the vallinoid receptors

Info

Publication number: AU3580001A
Authority: AU; Australia
Prior art keywords: vallinoid; endocannabinoid; modulators; uptake; receptors
Prior art date: 2000-03-01
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU35800/01A

Inventor

David Baker

Tiziana Bisogno

Luciano De Petrocellis

Vincenzo Di Marzo

Gareth Pryce

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

University College London

Original Assignee

University College London

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-03-01

Filing date

2001-02-28

Publication date

2001-09-12

2000-03-01 Priority claimed from GB0004895A external-priority patent/GB0004895D0/en

2000-11-16 Priority claimed from GB0027989A external-priority patent/GB0027989D0/en

2001-02-28 Application filed by University College London filed Critical University College London

2001-09-12 Publication of AU3580001A publication Critical patent/AU3580001A/en

Status Abandoned legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

AU35800/01A 2000-03-01 2001-02-28 Modulators of the endocannabinoid uptake and of the vallinoid receptors Abandoned AU3580001A (en)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
GB0004895A GB0004895D0 (en)	2000-03-01	2000-03-01	Inhibitor
GB0004895		2000-03-01
GB0027989A GB0027989D0 (en)	2000-11-16	2000-11-16	Modulator
GB0027989		2000-11-16
PCT/GB2001/000858 WO2001064212A1 (en)	2000-03-01	2001-02-28	Modulators of the endocannabinoid uptake and of the vallinoid receptors

Publications (1)

Publication Number	Publication Date
AU3580001A true AU3580001A (en)	2001-09-12

Family

ID=26243768

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU35800/01A Abandoned AU3580001A (en)	2000-03-01	2001-02-28	Modulators of the endocannabinoid uptake and of the vallinoid receptors

Country Status (2)

Country	Link
AU (1)	AU3580001A (en)
WO (1)	WO2001064212A1 (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
RU2543350C2 (en)	2003-01-28	2015-02-27	Айронвуд Фармасьютикалз, Инк.	Methods and compositions for treating gastrointestinal disorders
US7772188B2 (en)	2003-01-28	2010-08-10	Ironwood Pharmaceuticals, Inc.	Methods and compositions for the treatment of gastrointestinal disorders
EP2998314B1 (en)	2007-06-04	2020-01-22	Bausch Health Ireland Limited	Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
US8969514B2 (en)	2007-06-04	2015-03-03	Synergy Pharmaceuticals, Inc.	Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
EP2328910B1 (en)	2008-06-04	2014-08-06	Synergy Pharmaceuticals Inc.	Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
AU2009270833B2 (en)	2008-07-16	2015-02-19	Bausch Health Ireland Limited	Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
KR20170091783A (en)	2008-12-31	2017-08-09	알데릭스, 인코포레이티드	Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
WO2018129556A1 (en)	2017-01-09	2018-07-12	Ardelyx, Inc.	Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
US9616097B2 (en)	2010-09-15	2017-04-11	Synergy Pharmaceuticals, Inc.	Formulations of guanylate cyclase C agonists and methods of use
US10376481B2 (en)	2012-08-21	2019-08-13	Ardelyx, Inc.	Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
AU2013304812B2 (en)	2012-08-21	2016-06-09	Ardelyx, Inc.	Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
AU2014235215A1 (en)	2013-03-15	2015-10-01	Synergy Pharmaceuticals Inc.	Agonists of guanylate cyclase and their uses
EP2968439A2 (en)	2013-03-15	2016-01-20	Synergy Pharmaceuticals Inc.	Compositions useful for the treatment of gastrointestinal disorders
BR112015025805A2 (en)	2013-04-12	2017-07-25	Ardelyx Inc	nh3 binding compounds and methods for inhibiting phosphate transport
ES2981866T3 (en)	2013-06-05	2024-10-10	Bausch Health Ireland Ltd	Ultrapure guanylate cyclase C agonists, their preparation method and use
EP3565808A1 (en)	2017-01-09	2019-11-13	Ardelyx, Inc.	Compounds useful for treating gastrointestinal tract disorders
WO2018129557A1 (en)	2017-01-09	2018-07-12	Ardelyx, Inc.	Inhibitors of nhe-mediated antiport
TW202325306A (en)	2021-09-02	2023-07-01	美商天恩治療有限公司	Methods of improving growth and function of immune cells

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4681897A (en) *	1984-01-16	1987-07-21	The Procter & Gamble Company	Pharmaceutical products providing enhanced analgesia
JP2002517479A (en) *	1998-06-09	2002-06-18	ザ・ユニバ−シティ・オブ・コネチカット	Anandamide transporter inhibitors as analgesics
HN1998000027A (en) *	1998-08-19	1999-06-02	Bayer Ip Gmbh	Arylsulphonamides and analogues
US6509005B1 (en) *	1998-10-27	2003-01-21	Virginia Commonwealth University	Δ9 Tetrahydrocannabinol (Δ9 THC) solution metered dose inhaler

2001
- 2001-02-28 WO PCT/GB2001/000858 patent/WO2001064212A1/en active Application Filing
- 2001-02-28 AU AU35800/01A patent/AU3580001A/en not_active Abandoned

Also Published As

Publication number	Publication date
WO2001064212A1 (en)	2001-09-07

Publication	Publication Date	Title
AU3580001A (en)	2001-09-12	Modulators of the endocannabinoid uptake and of the vallinoid receptors
AU2002347328A1 (en)	2003-06-17	Fixing device and applicator therefor
AU2002338914A1 (en)	2002-12-03	Cosmetic agents
AU2002336234A1 (en)	2003-03-27	Dynamic mixer
AU2001229667A1 (en)	2001-07-31	Automatically modulating acupressure device
AU2001252135A1 (en)	2001-09-03	Therapeutic agents
AUPQ676800A0 (en)	2000-05-11	Dental device
AU2002224823A1 (en)	2002-05-27	Rubber compounds that contain gels and inorganic peroxides
AU2001273423A1 (en)	2002-02-05	Liquid applicator
AU2001292185A1 (en)	2002-04-22	Formulation containing amoxicillin
AU2001291072A1 (en)	2002-04-02	Releasable strap
AU2001286061A1 (en)	2002-03-26	Applicator
AU2001272974A1 (en)	2002-01-02	Human receptors
AU2002239454A1 (en)	2002-05-27	Ace-2 modulating compounds and use thereof
AU2001292936A1 (en)	2002-04-02	Octahydro-indolizines and quinolizines and hexahydro-pyrrolizines
AU2001235363A1 (en)	2001-09-03	Mibefradil analogues and their use
AU2001274523A1 (en)	2002-01-14	Liquid applicator
AU2001295185A1 (en)	2001-11-07	Multiplexing-interleaving and demultiplexing-deinterleaving
AU2001273903A1 (en)	2001-10-08	Therapeutic agents
AU2001252627A1 (en)	2002-01-31	Polybenzasol fiber and use of the same
AU2001253461A1 (en)	2001-10-30	Coated anchoring device
AU2001267584A1 (en)	2002-01-30	Dynamic mixer
AU2000231564A1 (en)	2001-08-27	Phosphororganic compounds and the use thereof
AU4432001A (en)	2001-10-08	Trityl-type compounds and their use
AU2001275696A1 (en)	2002-02-05	Therapeutic agent

Legal Events

Date	Code	Title	Description
2002-03-21	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase